Encellin Announces Interim Clinical Results Showing First-in-Human Non-Fibrotic Engraftment and Viable Encapsulated Human Islets in Subjects with Type 1 Diabetes

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
FiercePharma

Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials

A pair of phase 3 trials of Neurotech Pharmaceuticals’ encapsulated cell therapy implant have met their primary endpoints, positioning the biotech to talk to the FDA about bringing the treatment for a ...
Page Six

Blac Chyna’s breasts almost turned to ‘mush’ after implant reduction surgery led to ‘painful’ complications

Blac Chyna is starting 2024 on a “painful” note. The mom of two revealed that one of her breasts “got encapsulated” due to complications from her breast implant reduction surgery. “Quick story time ...
Healio

Study finds limited benefit from needling revision with MMC of failed Molteno implants

Please provide your email address to receive an email when new articles are posted on . Needling bleb revision with mitomycin-C can be used to manage failed encapsulated Molteno tube implants, ...